<code id='0EFCF4CA0A'></code><style id='0EFCF4CA0A'></style>
    • <acronym id='0EFCF4CA0A'></acronym>
      <center id='0EFCF4CA0A'><center id='0EFCF4CA0A'><tfoot id='0EFCF4CA0A'></tfoot></center><abbr id='0EFCF4CA0A'><dir id='0EFCF4CA0A'><tfoot id='0EFCF4CA0A'></tfoot><noframes id='0EFCF4CA0A'>

    • <optgroup id='0EFCF4CA0A'><strike id='0EFCF4CA0A'><sup id='0EFCF4CA0A'></sup></strike><code id='0EFCF4CA0A'></code></optgroup>
        1. <b id='0EFCF4CA0A'><label id='0EFCF4CA0A'><select id='0EFCF4CA0A'><dt id='0EFCF4CA0A'><span id='0EFCF4CA0A'></span></dt></select></label></b><u id='0EFCF4CA0A'></u>
          <i id='0EFCF4CA0A'><strike id='0EFCF4CA0A'><tt id='0EFCF4CA0A'><pre id='0EFCF4CA0A'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:994
          Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT
          Darron Cummings/AP

          LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

          Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

          advertisement

          But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Health AI: on the border between health care and tech
          Health AI: on the border between health care and tech

          AdobeThere’sbeensignificantinvestmentincompaniescreatingartificialintelligence(AI)applicationsforhea

          read more
          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more

          State of the Union pitch: Bigger Medicare drug price negotiations

          InhisStateoftheUnionaddress,PresidentBidenwillproposeexpandingseveralofDemocrats'drugpricingreformsi